Kamboj Meenakshi, Mehta Anurag, Pasricha Sunil, Gupta Gurudutt, Sharma Anila, Durga Garima
Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
J Cytol. 2022 Jan-Mar;39(1):44-50. doi: 10.4103/JOC.JOC_79_20. Epub 2022 Jan 31.
The objective of this study was to report the experience of an Indian premiere tertiary care oncology center in reporting fine needle aspiration cytology of thyroid lesions according to the Bethesda system of reporting thyroid cytopathology (TBSRTC) given by National Cancer Institute (NCI). These were then correlated with their histopathological outcome, analyzing the level of specificity and sensitivity of the procedure.
Aspiration cytology of thyroid lesions, presented during a 5.5-year duration, was reported retrospectively and prospectively, according TBSRTC, and correlated with their histopathologic diagnosis.
A total of 431 patients were evaluated comprising 289 females and 142 males, with a median age of 52 years. Among the cytological categories 80 (18.6%) were non-diagnostic (ND), 131 (30.2%) benign, 45 (10.4%) follicular lesion of undetermined significance (FLUS), 27 (6.3%) follicular neoplasm, 33 (7.9%) suspicious for malignancy (SM), and 115 (26.7%) malignant. Histopathology reports were available in 142 of these cases. Final malignant diagnosis was reported in 11 of 14 ND (78.6%), 5 of 18 benign cases (27.7%); 9 of 17 FLUS (52.9%), 7 of 13 FLUS (53.89%), 19 of 20 SM (95%), and 58 of 60 malignant cases (96.7%). The procedure had sensitivity of 94.4%, specificity of 61.9%, positive predictive value of 90.3% and negative predictive value of 72.22%.
TBSRTC provides uniform categorization of thyroid cytology, which also helps in further management. This valid system has helped to streamline the reporting terminologies as well as the clinical management.
本研究的目的是报告一家印度一流的三级护理肿瘤中心根据美国国立癌症研究所(NCI)给出的甲状腺细胞病理学报告贝塞斯达系统(TBSRTC)报告甲状腺病变细针穿刺细胞学检查的经验。然后将这些结果与其组织病理学结果相关联,分析该检查方法的特异性和敏感性水平。
回顾性和前瞻性地报告了在5.5年期间出现的甲状腺病变的穿刺细胞学检查结果,并根据TBSRTC进行分类,同时将其与组织病理学诊断结果相关联。
共评估了431例患者,其中女性289例,男性142例,中位年龄为52岁。在细胞学分类中,80例(18.6%)为非诊断性(ND),131例(30.2%)为良性,45例(10.4%)为意义未明的滤泡性病变(FLUS),27例(6.3%)为滤泡性肿瘤,33例(7.9%)为可疑恶性(SM),115例(26.7%)为恶性。其中142例病例有组织病理学报告。最终恶性诊断在14例ND中的11例(78.6%)、18例良性病例中的5例(27.7%)、17例FLUS中的9例(52.9%)、13例FLUS中的7例(53.89%)、20例SM中的19例(95%)以及60例恶性病例中的58例(96.7%)中得到报告。该检查方法的敏感性为94.4%,特异性为61.9%,阳性预测值为90.3%,阴性预测值为72.22%。
TBSRTC为甲状腺细胞学提供了统一的分类,这也有助于进一步的管理。这个有效的系统有助于简化报告术语以及临床管理。